Recruitment

Recruitment Status
Recruiting

Inclusion Criteria

The patient must have a verified diagnosis of an urologic cancer by a board-certified clinician
The patient is able to provide written informed consent and is at least 18 years of age
The patient must have a verified diagnosis of an urologic cancer by a board-certified clinician
The patient is able to provide written informed consent and is at least 18 years of age

Exclusion Criteria

The patient has a severe psychiatric illness, imprisonment or mental impairment inflicting on ability to give informed consent
The patient is not willing to provide a written informed consent
The patient has a severe psychiatric illness, imprisonment or mental impairment inflicting on ability to give informed consent
The patient is not willing to provide a written informed consent

Summary

Conditions
  • Kidney Cancer
  • Penile Cancer
  • Prostate Carcinoma
  • Testicular Cancer
  • Urothelial Carcinoma
Type
Interventional
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Access to high-quality clinical patient material (e.g. tissue of primary tumor and metastasis, plasma and urine) linked to comprehensive registry and clinical data and molecular characterization of the patient material using state-of-the-art technologies (e.g. NGS, transcriptomics, imaging, DSRT) wi...

Access to high-quality clinical patient material (e.g. tissue of primary tumor and metastasis, plasma and urine) linked to comprehensive registry and clinical data and molecular characterization of the patient material using state-of-the-art technologies (e.g. NGS, transcriptomics, imaging, DSRT) will facilitate a more rapid translation of basic research innovations into clinical care (diagnostics, imaging, therapeutics) and result in improved outcome of patients suffering from urologic cancers ("personalized medicine"). The principal aim of the project is to establish a framework and infrastructure for the systematic collection and interpretation of biological patient samples. Similarly, the investigators aim to establish the format how the related clinical and research data can be made readily accessible for both clinicians and researchers without compromising patient privacy. The key objectives of the project are to facilitate research translation and to improve outcome of urologic cancers.

Inclusion Criteria

The patient must have a verified diagnosis of an urologic cancer by a board-certified clinician
The patient is able to provide written informed consent and is at least 18 years of age
The patient must have a verified diagnosis of an urologic cancer by a board-certified clinician
The patient is able to provide written informed consent and is at least 18 years of age

Exclusion Criteria

The patient has a severe psychiatric illness, imprisonment or mental impairment inflicting on ability to give informed consent
The patient is not willing to provide a written informed consent
The patient has a severe psychiatric illness, imprisonment or mental impairment inflicting on ability to give informed consent
The patient is not willing to provide a written informed consent

Locations

Helsinki, Uusimaa, 00029
Helsinki, Uusimaa, 00029

Tracking Information

NCT #
NCT02994758
Collaborators
Karolinska Institutet
Investigators
  • Principal Investigator: Antti S Rannikko, MD, PhD Helsinki University Central Hospital
  • Antti S Rannikko, MD, PhD Helsinki University Central Hospital